Field effectiveness of live attenuated measles-containing vaccines: A review of published literature

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Uzicanin, Amra ^a   Zimmerman, Laura ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; LIVE VACCINE;

DRUG EFFICACY; HUMAN; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MEDICAL INFORMATION; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEROLOGY; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; VIRUS STRAIN; WORLD HEALTH ORGANIZATION; AGE; IMMUNIZATION; INFANT; POLICY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; STANDARD;

AGE FACTORS; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MEASLES; MEASLES VACCINE; PUBLIC POLICY; VACCINES, ATTENUATED;

EID: 79960862424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir102     Document Type: Review

References (88)

1. Strebel P, Papania M. Measles vaccine. In Plotkin S, Orenstein W, Offit P eds. Vaccines. 5th ed. Philadelphia: Elsevier, 2008: 353-98.
2. Cutts FT, Grabowsky M, Markowitz LE. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals 1995; 23:95-106.
3. WHO. Measles: The immunological basis for immunization, 2009. http://whqlibdoc.who.int/publications/2009/9789241597555-eng.pdf. Accessed 25 October 2010.
4. Peltola H, Davidkin D, Valle M, et al. No measles in Finland. Lancet 1997; 350:1364-75.
5. De Quadros C, Hersch B, Nogueira A, et al. Measles eradication: experience in the America's. MMWR 1999; 48(Suppl 1):57-64.
6. UNICEF. http://www.unicef.org/immunization/index-measles.html. Accessed 18 October 2010.
7. Dabbagh A, Gacic-Dobo M, Simons E, et al. Global measles mortality, 2000-2008. MMWR 2009; 58:1321-6.
8. WHO. Measles position paper, 2009. http://www.who.int/wer/2009/wer8435. pdf. Accessed 25 October 2010.
9. WHO. http://apps.who.int/gb/ebwha/pdf-files/EB126/B126-17-en.pdf. Accessed 18 October 2010.
10. WHO. http://www.who.int/immunization/sage/Analysis-Feasibility-Global- Measles-Elimination.pdf. Accessed 18 October 2010.
11. Orenstein W, Bernier R, Dondero T, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-68.
12. WHO. Measles vaccine. Wkly Epidemol Rec 2004; 79:130-42.
13. Hull H, Williams P, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983: 321:972-5.
14. Cutts F, Smit P, Colomno S. Filed evelaution of measles vaccine efficacy in Mozambique. Am J Epidemol 1990; 131:349-55.
15. Marufu T, Siziya S, Manyame B. Questioning the level of efficacy of the measles vaccine in use in Zimbawe. Cent Afr J Med 1995; 41:241-5.
16. Mudzamiri W, Peterson D, Marufu T, et al. Measles vaccine efficacy in Masvingo District, Zimbabwe. Cent Afr J Med 1996; 42:195-7.
17. Chen R, Weierbach R, Bisoffi Z, et al. A post-honeymoon period measles outbreak in Muyinga Sector, Burundi. Int J Epidemol 1994; 23:185-93.
18. Malfait P, Jatou I, Jollet MC. Measles epidemic in the urban community of Niamrey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. Pediatr Infect Dis J 1994; 13:38-45.
19. Weeks R, Barenz J, Wayira J. A low-cost, community-based measles outbreak investigation with follow-up action. Bull Worrld Health Organ 1992; 70:317-21.
20. Simba D, Msaanga G. Measles vaccine effectiveness under filed conditions: a case control study in Tabora region, Tanzania. Trop Geogr Med 1995; 47:197-9.
21. Ndikuyeze A, Cook A, Cutts F. Priorities in global measles control: report of an outbreak in N'Djamena, Chad. Epidemiol Infect 1995; 115:309-14.
22. Kaninda A, Legros D, Jatoou I, et al. Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995. Pediatr Iinfect Dis J 1998; 17:1034-9.
23. Borus K, Cumberland P, Sonoya J, et al. Measles trends and vaccine effectiveness in Nairobi, Kenya. East Afr Med J 2003: 80:361-4.
24. Mahomva A, Moyo I, Mbengeranwa L. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe. Cent Afr J Med 1997; 43:254-6.
25. Mupere E, Karamagi C, Zirembuzi G. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Vaccine 2006; 24:4111-5.
26. Talley L, Salama P. Short report: assessing field vaccine efficacy for measles in famine-affected rural Ethiopia. Am J Trop Med Hyg 2003; 68:545-6.
27. McMorrow M, Gebremedhim G, vanden Heever J. Measles outbreak in South Africa, 2003-2005. S Afr Med J 2009; 99:314-9.
28. Lerman S, Gold E. Measles in children previously vaccinated against measles. JAMA 1971; 216:1311-4.
29. Landrigan P. Epidemic measles in a divided city. JAMA 1972; 221:567-70.
30. Wyall S, Witte J. Measles in previously vaccinated children. JAMA 1971; 216:1306-10.
31. Andrews D, McElroy J. Measles outbreak in northeastern Connecticut epidemiology and vaccine efficacy. Conn Med 1974: 38:411-2.
32. Ziskin L, Dimasi L. Measles epidemic in New Jersey: vaccine efficacy study in a well-protected population. J Med Soc N J 1976: 73:1069-71.
33. Marks J, Halpin T, Orenstein W. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics 1978; 62:955-60.
34. Guasparini R, Sheps S, Mathias R, et al. Measles outbreak in a Vancouver school population: relative risk and vaccine efficacy. Can J Public Health 1988; 79:26-30.
35. Nkowane B, Bart S, Orenstein W, et al. Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failure. Am J Public Health 1987; 77:334-8.
36. Davis R, Eric D, Orenstein W, et al. A persistent outbreak of mealses despite appropriate prevention and control measures. Am J Epidemol 1987; 126:438-49.
37. Mast E, Berg J, Hanrahan L, et al. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 1991; 5:439-44.
38. Robertson S, Markowitz L, Berry D, et al. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep 1992; 107:24-31.
39. Hersh B, Markowitz L, Hoffman R. A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health 1991; 81:360-4.
40. de Serres G, Boulianne N, Meyer F, et al. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months. Epidemiol Infect 1995; 115:315-23.
41. King G, Markowitz L, Patriarca P, et al. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Iinfect Dis J 1991; 10:883-7.
42. Vitek C, Adudell M, Brinton M, et al. Increased protection during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatr Iinfect Dis J 1999; 18:620-3.
43. Rivest P, Bedard L, Arruda H, et al. Risk factors for measles and vaccine efficacu during an epidemic in Montreal. RCan J Public Health 1995; 86:86-90.
44. Sutcliffe P, Rea E. Outbreak of measles in a highly vaccinated secondary school population. Can Med Assoc J 1996; 155:1407-13.
45. Lynn T, Beller M, Funk E, et al. Incremental effectiveness of 2 dose of measles-containing vaccine compared with 1 dose among high school students during an outbreak. J Infect Dis 2004; 189(Suppl 1):S86-S90.
46. Yeung L, Perrianne L, Dayan G, et al. A, limited measles outbreak in a highly vaccinated US boarding school. Pediatrics 2005; 116:1287-91.
47. Murray M, Rasmussen Z. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness. Amer J Epidemiol 2000; 152:811-9.
48. Kotb M, Khella A, Allarn M. Evaluation of the effectiveness of routine measles vaccination: case control study. J Egypt Public Health Assoc 1999; 1:59-68.
49. Agocs M, Markowitz L, Straub I. The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure. Int J Epidemol 1992; 21:1007-13.
50. Lyons R, Jones H, Salmon R. Successful control of a school based measles outbreak by immunization. Epidemiol Infect 1994; 113:367-5.
51. Tohani V, Kennedy F. vaccine efficacy in a measles immunization programme. Comm Dis Rep 1992; 2:R59-60.
52. Morse D, O'Shea M, Hamilton G, et al. Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents. Epidemiol Infect 1994; 113:355-65.
53. Beneveto and Compobasso Pediatricians Network for the control of vaccine-preventable Diseases. Vaccine 1998; 16:818-22.
54. Mossong J, Muller C. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect 2000; 124:273-8.
55. Hennessay K, Ion-Nedelcu N, Craciun M. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemol 1999; 150: 1250-6.
56. Janaszek W, Gay N, Gut W. Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland. Vaccine 2002; 21:473-8.
57. Arenz S, Schmitt H, Tischer A, et al. Effectiveness of measles vaccination after a household exposure during a measles outbreak: a household contact study in Coburg, Bavaria. Pediatr Infect Dis J 2005; 24:697-9.
58. Doshi S, Khetsurianai N, Zakhashvilli K, et al. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts. Int J Epidemol 2009; 38:182-91.
59. Wichmann O, Hellenbrand W, Sagabiel D, et al. Large outbreak measles outbreak at a German public school, 2006. Pediatr Infect Dis J 2007; 26:782-6.
60. Velicko I, Muller L, Pebody R, et al. Nationwide measles epidemic in Ukraine: the effect of low vaccination effectiveness. Vaccine 2008; 26:6980-5.
61. Schmid D, Holzman H, Schwarz K, et al. measles outbreak linked to a minority group in Austria, 2008. Epidemiol Infect 2010; 138:415-25.
62. Sharma R, Chawla U, Datta K. Field evaluation of measles vaccine efficacy in Najafgarh Zone of Delhi. J Commun Dis 1998; 20:38-43.
63. Chawla U, Benera S, Bandyopadhyan S, et al. Field evaluatation of measles vaccine efficacy in New Semmapuri, Shahara Zone-Delhi during 1990. J Com Dis 1990; 22:134-9.
64. Akramuzzaman S, Cutts F, Hossain M, et al. Bull World Health Organ 2002; 80:776-82.
65. John S, Sanghi S, Prasad S, et al. Two doses of measles vaccine: are some states in India ready for it. J Trop Pediatr 2008; 55:253-6.
66. Lertripiriyasuwat C, Deeying J, Thepsoontorn S, et al. Measles outbreak in an orphanage, Bangkok, Thailand, September-October 2000. J Med Assoc Thai 2002; 85:653-7.
67. Puri A, Gupta V, Chakravarti A, et al. Measles vaccine efficacy evaluated by case reference technique. Indian Pediatr 2002; 39: 556-60.
68. John S, Sanghi S, Prasad S, et al. Two doses of measles vaccine: are some states in India ready for it? J Trop Pediatr 2008; 55:254-6.
69. McIntyre R, Preblud S, Polloi A, et al. Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ 1982; 60:767-75.
70. Gao J, Malison M. The epidemiology of a measles outbreak on a remote offshore island near Taiwan. Int J Epidemol 1988; 17:894-8.
71. Cheah D, Lane J, Passaris L. Measles vaccine efficacy study in a Canberra high school: a study following a measles outbreak. J Paediatr Child Health 1993; 29:455-8.
72. An estimate of measles vaccine efficacy in a Canberra primary school. Wkly Epidemiol Rec 1993; 68:117-24.
73. Herceg A, Passaris I, Mead C. An outbreak of measles in a highly immunized population: immunization status and vaccine efficacy. Aust J Public Health 1994; 18:249-52.
74. McDonnell L, Jorm L, Patel M. Measles outbreak in western Sydney, vaccine failure or failure to vaccinate. Med J Aust 1995; 162:471-5.
75. Srirajalinggam M, Sheidan J. Estimation of measles vaccination coverage and longer-term vaccine efficacy in a Queensland State high school during 1993-94 measles epidemic. Aust N Z J Public Health 1998; 22:792-5.
76. Kim S, Son B, Chung C, et al. Efficacy of measles vaccine during the 1993 measles epidemic in Korea. Pediatr Infect Dis J 1995; 14:346-9.
77. Guris D, McCready J, Watson J. Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting expose to measles virus. Pediatr Infect Dis J 1996; 15:1082-6.
78. Patel M, Lush D. Measles vaccine effectiveness in central Australian Aboriginal children vaccinated at or after eight months of age. Aust N Z J Public Health 1998; 22:729-30.
79. Lee M, Lee L, Hour-Young C, et al. Post mass-immunization measles outbreak in Taoyuan County, Taiwan: dynamics of transmission, vaccine effectiveness, and herd immunity. Int J Infect Dis 1998-1999; 3:64-9.
80. Gidding H, Hills S, Selvey L, et al. An outbreak of measles in a rural Queensland town in 1997; an opportunity to assess vaccine effectiveness. Commun Dis Intell 1999; 23:240-5.
81. Mori N, Ohkusa Y, Ohyama T, et al. Estimation of measles vaccine coverage needed to prevent transmission in schools. Pediatr Int 2008; 50:464-8.
82. Marin M, Nguyen H, Langidrik J, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island, implications for vaccination policy. Clin Infect Dis 2006; 42:315-9.
83. Ong G, Wan S, Cutter J. Outbreak of measles in primary school students with high first dose MMR vaccination coverage. Singapore Med J 2007; 48:656-61.
84. Sheppeard V, Forssman B, Ferson M, et al. Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May, 2006. Commun Dis Intell 2009; 32:21-6.
85. Leuridan E, Hens N, Hutse V, et al. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010; 340:c1626.
86. Hinman A, Orenstein W, Papania M. Evolution of measles elimination strategies in the United States. J Infect Dis 2004; 189(Suppl 1):S17-22.
87. Redd S, Kutty P, Parker A, et al. Measles-United States, January 1-April 25, 2008. MMWR 2008; 57:494-8.
88. Grigg M, Brezny A, Dawson J, et al. Measles-United States, January- July, 2008. MMWR 2008; 57:893-6.